Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Stroke

Free Subscription Articles published in BMJ Retrieve available abstracts of 90 articles: HTML format

Single Articles

June 2021
1. BURNS TC, Quinones-Hinojosa A
   Regenerative medicine for neurological diseases-will regenerative neurosurgery deliver?
   BMJ. 2021;373:n955.
   PubMed     Abstract available
   
   
   
2. VALGIMIGLI M, Gragnano F, Branca M, Franzone A, et al
   P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
   BMJ. 2021;373:n1332.
   PubMed     Abstract available
   
   
   
3. KOVACS MJ, Wells PS, Anderson DR, Lazo-Langner A, et al
   Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
   BMJ. 2021;373:n1205.
   PubMed     Abstract available
   
   
   May 2021
4. PERRY M, Kemmis Betty S, Downes N, Andrews N, et al
   Atrial fibrillation: diagnosis and management-summary of NICE guidance.
   BMJ. 2021;373:n1150.
   PubMed    
   
   
   
5. KIM D, Yang PS, You SC, Sung JH, et al
   Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study.
   BMJ. 2021;373:n991.
   PubMed     Abstract available
   
   
   April 2021
6. PONAMGI SP, Siontis KC, Rushlow DR, Graff-Radford J, et al
   Screening and management of atrial fibrillation in primary care.
   BMJ. 2021;373:n379.
   PubMed     Abstract available
   
   
   
7. WOOD A, Denholm R, Hollings S, Cooper J, et al
   Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.
   BMJ. 2021;373:n826.
   PubMed     Abstract available
   
   
   February 2021
8. 
   Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study.
   BMJ. 2021;372:n453.
   PubMed    
   
   
   
9. PERRY JJ, Sivilotti MLA, Emond M, Stiell IG, et al
   Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre prospective cohort study.
   BMJ. 2021;372:n49.
   PubMed     Abstract available
   
   
   October 2020
10. WANG DZ, Schwamm LH, Qian T, Dai Q, et al
    Decoding the brain through research-the future of brain health.
    BMJ. 2020;371:m3735.
    PubMed    
    
    
    September 2020
11. FILION KB, Lix LM, Yu OH, Dell'Aniello S, et al
    Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.
    BMJ. 2020;370:m3342.
    PubMed     Abstract available
    
    
    July 2020
12. CAI X, Zhang Y, Li M, Wu JH, et al
    Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis.
    BMJ. 2020;370:m2297.
    PubMed     Abstract available
    
    
    April 2020
13. MARKLUND M, Singh G, Greer R, Cudhea F, et al
    Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study.
    BMJ. 2020;369:m824.
    PubMed     Abstract available
    
    
    March 2020
14. COOK R, Davidson P, Martin R
    Computerised speech and language therapy can help people with aphasia find words following a stroke.
    BMJ. 2020;368:m520.
    PubMed     Abstract available
    
    
    February 2020
15. PHIPPS MS, Cronin CA
    Management of acute ischemic stroke.
    BMJ. 2020;368:l6983.
    PubMed     Abstract available
    
    
    December 2019
16. TIAN Y, Liu H, Wu Y, Si Y, et al
    Association between ambient fine particulate pollution and hospital admissions for cause specific cardiovascular disease: time series study in 184 major Chinese cities.
    BMJ. 2019;367:l6572.
    PubMed     Abstract available
    
    
    
17. HUANG K, Liang F, Yang X, Liu F, et al
    Long term exposure to ambient fine particulate matter and incidence of stroke: prospective cohort study from the China-PAR project.
    BMJ. 2019;367:l6720.
    PubMed     Abstract available
    
    
    November 2019
18. PAPANICOLAS I, Mossialos E, Gundersen A, Woskie L, et al
    Performance of UK National Health Service compared with other high income countries: observational study.
    BMJ. 2019;367:l6326.
    PubMed     Abstract available
    
    
    
19. MCKENNA-BARRY MT, Ryan JD
    Studies on non-alcoholic fatty liver disease should stratify by disease severity.
    BMJ. 2019;367:l6495.
    PubMed    
    
    
    
20. SATTAR N, Alazawi W
    Authors' reply to McKenna-Barry and Ryan.
    BMJ. 2019;367:l6549.
    PubMed    
    
    
    October 2019
21. ALEXANDER M, Loomis AK, van der Lei J, Duarte-Salles T, et al
    Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
    BMJ. 2019;367:l5367.
    PubMed     Abstract available
    
    
    September 2019
22. KIM NH, Han KH, Choi J, Lee J, et al
    Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study.
    BMJ. 2019;366:l5125.
    PubMed     Abstract available
    
    
    
23. NAVE AH, Rackoll T, Grittner U, Blasing H, et al
    Physical Fitness Training in Patients with Subacute Stroke (PHYS-STROKE): multicentre, randomised controlled, endpoint blinded trial.
    BMJ. 2019;366:l5101.
    PubMed     Abstract available
    
    
    
24. KASKI D, Agarwal K, Murdin L
    Acute vertigo.
    BMJ. 2019;366:l5215.
    PubMed    
    
    
    
25. TONG TYN, Appleby PN, Bradbury KE, Perez-Cornago A, et al
    Risks of ischaemic heart disease and stroke in meat eaters, fish eaters, and vegetarians over 18 years of follow-up: results from the prospective EPIC-Oxford study.
    BMJ. 2019;366:l4897.
    PubMed     Abstract available
    
    
    
26. LAWRENCE MA, McNaughton SA
    Vegetarian diets and health.
    BMJ. 2019;366:l5272.
    PubMed    
    
    
    August 2019
27. PASTERNAK B, Ueda P, Eliasson B, Svensson AM, et al
    Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study.
    BMJ. 2019;366:l4772.
    PubMed     Abstract available
    
    
    July 2019
28. 
    Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults.
    BMJ. 2019;366:l4934.
    PubMed    
    
    
    June 2019
29. ROY MP
    Stroke burden in India and strategies for mitigation.
    BMJ. 2019;365:l4243.
    PubMed    
    
    
    
30. WANG Y, Chen W, Lin Y, Meng X, et al
    Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
    BMJ. 2019;365:l2211.
    PubMed     Abstract available
    
    
    May 2019
31. SEMINOG OO, Scarborough P, Wright FL, Rayner M, et al
    Determinants of the decline in mortality from acute stroke in England: linked national database study of 795 869 adults.
    BMJ. 2019;365:l1778.
    PubMed     Abstract available
    
    
    
32. MA H, Li X, Sun D, Zhou T, et al
    Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank.
    BMJ. 2019;365:l1628.
    PubMed     Abstract available
    
    
    April 2019
33. 
    Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis.
    BMJ. 2019;365:l1658.
    PubMed    
    
    
    February 2019
34. WANG Y, Johnston SC, Bath PM, Grotta JC, et al
    Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack.
    BMJ. 2019;364:l895.
    PubMed    
    
    
    
35. LI Z, Jiang Y, Li H, Xian Y, et al
    China's response to the rising stroke burden.
    BMJ. 2019;364:l879.
    PubMed    
    
    
    
36. LOWN M, Moran P
    Should we screen for atrial fibrillation?
    BMJ. 2019;364:l43.
    PubMed    
    
    
    
37. AGARWAL A, Ioannidis JPA
    PREDIMED trial of Mediterranean diet: retracted, republished, still trusted?
    BMJ. 2019;364:l341.
    PubMed    
    
    
    January 2019
38. MORRIS S, Ramsay AIG, Boaden RJ, Hunter RM, et al
    Impact and sustainability of centralising acute stroke services in English metropolitan areas: retrospective analysis of hospital episode statistics and stroke national audit data.
    BMJ. 2019;364:l1.
    PubMed     Abstract available
    
    
    
39. 
    Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
    BMJ. 2019;364:l103.
    PubMed    
    
    
    December 2018
40. PRASAD K, Siemieniuk R, Hao Q, Guyatt G, et al
    Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke: a clinical practice guideline.
    BMJ. 2018;363:k5130.
    PubMed     Abstract available
    
    
    
41. HAO Q, Tampi M, O'Donnell M, Foroutan F, et al
    Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis.
    BMJ. 2018;363:k5108.
    PubMed     Abstract available
    
    
    November 2018
42. MAYOR S
    Thrombectomy can be considered up to 24 hours after onset of stroke, says NICE.
    BMJ. 2018;363:k4995.
    PubMed    
    
    
    October 2018
43. CHEN R, Yin P, Wang L, Liu C, et al
    Association between ambient temperature and mortality risk and burden: time series study in 272 main Chinese cities.
    BMJ. 2018;363:k4306.
    PubMed     Abstract available
    
    
    
44. RUTTEN-JACOBS LC, Larsson SC, Malik R, Rannikmae K, et al
    Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: cohort study of 306 473 UK Biobank participants.
    BMJ. 2018;363:k4168.
    PubMed     Abstract available
    
    
    
45. SIEMIENIUK RAC, Chu DK, Kim LH, Guell-Rous MR, et al
    Oxygen therapy for acutely ill medical patients: a clinical practice guideline.
    BMJ. 2018;363:k4169.
    PubMed    
    
    
    September 2018
46. NISHIKAWA G, Prasad V
    Diagnostic expansion in clinical trials: myocardial infarction, stroke, cancer recurrence, and metastases may not be the hard endpoints you thought they were.
    BMJ. 2018;362:k3783.
    PubMed    
    
    
    
47. SCHMIDT M, Sorensen HT, Pedersen L
    Diclofenac use and cardiovascular risks: series of nationwide cohort studies.
    BMJ. 2018;362:k3426.
    PubMed     Abstract available
    
    
    July 2018
48. KUIJPERS T, Spencer FA, Siemieniuk RAC, Vandvik PO, et al
    Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline.
    BMJ. 2018;362:k2515.
    PubMed    
    
    
    
49. DOUROS A, Dell'Aniello S, Yu OHY, Filion KB, et al
    Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study.
    BMJ. 2018;362:k2693.
    PubMed     Abstract available
    
    
    
50. VINOGRADOVA Y, Coupland C, Hill T, Hippisley-Cox J, et al
    Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.
    BMJ. 2018;362:k2505.
    PubMed     Abstract available
    
    
    May 2018
51. RICCI C, Wood A, Muller D, Gunter MJ, et al
    Alcohol intake in relation to non-fatal and fatal coronary heart disease and stroke: EPIC-CVD case-cohort study.
    BMJ. 2018;361:k934.
    PubMed     Abstract available
    
    
    
52. ADDERLEY NJ, Nirantharakumar K, Marshall T
    Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies.
    BMJ. 2018;361:k1717.
    PubMed     Abstract available
    
    
    April 2018
53. BANERJEE G, Stone SP, Werring DJ
    Posterior circulation ischaemic stroke.
    BMJ. 2018;361:k1185.
    PubMed    
    
    
    March 2018
54. JANSEN IGH, Mulder MJHL, Goldhoorn RB
    Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN Registry).
    BMJ. 2018;360:k949.
    PubMed     Abstract available
    
    
    February 2018
55. KUMAR S, de Lusignan S, McGovern A, Correa A, et al
    Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
    BMJ. 2018;360:k342.
    PubMed     Abstract available
    
    
    January 2018
56. ADELBORG K, Szepligeti SK, Holland-Bill L, Ehrenstein V, et al
    Migraine and risk of cardiovascular diseases: Danish population based matched cohort study.
    BMJ. 2018;360:k96.
    PubMed     Abstract available
    
    
    
57. HACKSHAW A, Morris JK, Boniface S, Tang JL, et al
    Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports.
    BMJ. 2018;360:j5855.
    PubMed     Abstract available
    
    
    November 2017
58. LOPEZ-LOPEZ JA, Sterne JAC, Thom HHZ, Higgins JPT, et al
    Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2017;359:j5058.
    PubMed     Abstract available
    
    
    
59. BALL J
    Which anticoagulant for stroke prevention in atrial fibrillation?
    BMJ. 2017;359:j5399.
    PubMed    
    
    
    May 2017
60. MERINO JG
    Selecting patients for endovascular treatment of acute stroke.
    BMJ. 2017;357:j2059.
    PubMed    
    
    
    
61. VENEMA E, Mulder MJHL, Roozenbeek B, Broderick JP, et al
    Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials.
    BMJ. 2017;357:j1710.
    PubMed     Abstract available
    
    
    April 2017
62. GULLAND A
    NHS thrombectomy plan needs more doctors, say stroke experts.
    BMJ. 2017;357:j1861.
    PubMed    
    
    
    
63. MAYOR S
    Ischaemic stroke in younger adults is increasing, US study finds.
    BMJ. 2017;357:j1815.
    PubMed    
    
    
    
64. HAWKES N
    The BMJ Awards 2017: Education.
    BMJ. 2017;357:j1720.
    PubMed    
    
    
    March 2017
65. BELL S, Daskalopoulou M, Rapsomaniki E, George J, et al
    Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records.
    BMJ. 2017;356:j909.
    PubMed     Abstract available
    
    
    
66. WISE J
    History of migraine may indicate risk of ischaemic stroke.
    BMJ. 2017;356:j1193.
    PubMed    
    
    
    February 2017
67. NIELSEN PB, Skjoth F, Sogaard M, Kjaeldgaard JN, et al
    Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ. 2017;356:j510.
    PubMed     Abstract available
    
    
    January 2017
68. TOWERS J
    Lindsey Dow.
    BMJ. 2017;356:j150.
    PubMed    
    
    
    
69. TIMM FP, Houle TT, Grabitz SD, Lihn AL, et al
    Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study.
    BMJ. 2017;356:i6635.
    PubMed     Abstract available
    
    
    November 2016
70. GULLAND A
    RCP warns over shortage of stroke physicians.
    BMJ. 2016;355:i6398.
    PubMed    
    
    
    
71. WALLACH JD, Sullivan PG, Trepanowski JF, Steyerberg EW, et al
    Sex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses.
    BMJ. 2016;355:i5826.
    PubMed     Abstract available
    
    
    
72. MAYOR S
    Moderate alcohol intake is linked to lower risk of ischaemic stroke, study finds.
    BMJ. 2016;355:i6339.
    PubMed    
    
    
    
73. MAYOR S
    More than half of stroke patients were not given preventive drugs, study finds.
    BMJ. 2016;355:i6105.
    PubMed    
    
    
    
74. SUKKAR L, Hong D, Wong MG, Badve SV, et al
    Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.
    BMJ. 2016;355:i5599.
    PubMed     Abstract available
    
    
    October 2016
75. 
    Poor adherence to antihypertensive drugs.
    BMJ. 2016;355:i5606.
    PubMed    
    
    
    
76. TORJESEN I
    Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows.
    BMJ. 2016;355:i5362.
    PubMed    
    
    
    September 2016
77. JOHNSON LR
    Current physical activity guidance is misinterpreted.
    BMJ. 2016;354:i4811.
    PubMed    
    
    
    August 2016
78. WISE J
    Most patients taking warfarin do not maintain stable INR values.
    BMJ. 2016;354:i4402.
    PubMed    
    
    
    June 2016
79. DYER O
    Egyptian prosecutors investigate the death of a girl during female genital mutilation.
    BMJ. 2016;353:i3133.
    PubMed    
    
    
    January 2016
80. WEILL A, Dalichampt M, Raguideau F, Ricordeau P, et al
    Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.
    BMJ. 2016;353:i2002.
    PubMed     Abstract available
    
    
    
81. MAYOR S
    Risk of stroke after transient ischaemic attack is lower than previously thought, study finds.
    BMJ. 2016;353:i2320.
    PubMed    
    
    
    
82. MAYOR S
    Air pollution is a leading risk factor for stroke, global study shows.
    BMJ. 2016;353:i3272.
    PubMed    
    
    
    
83. TIMMIS A, Rapsomaniki E, Chung SC, Pujades-Rodriguez M, et al
    Prolonged dual antiplatelet therapy in stable coronary disease: comparative observational study of benefits and harms in unselected versus trial populations.
    BMJ. 2016;353:i3163.
    PubMed     Abstract available
    
    
    
84. LARSEN TB, Skjoth F, Nielsen PB, Kjaeldgaard JN, et al
    Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ. 2016;353:i3189.
    PubMed     Abstract available
    
    
    
85. JASPERS FOCKS J, Brouwer MA, Wojdyla DM, Thomas L, et al
    Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial.
    BMJ. 2016;353:i2868.
    PubMed     Abstract available
    
    
    
86. LI L, Rothwell PM
    Biases in detection of apparent "weekend effect" on outcome with administrative coding data: population based study of stroke.
    BMJ. 2016;353:i2648.
    PubMed     Abstract available
    
    
    
87. MAYOR S
    Older people with anaemia have higher mortality after stroke, finds study.
    BMJ. 2016;354:i4577.
    PubMed    
    
    
    
88. KYU HH, Bachman VF, Alexander LT, Mumford JE, et al
    Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013.
    BMJ. 2016;354:i3857.
    PubMed     Abstract available
    
    
    
89. ADAMSSON ERYD S, Gudbjornsdottir S, Manhem K, Rosengren A, et al
    Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study.
    BMJ. 2016;354:i4070.
    PubMed     Abstract available
    
    
    
90. ODUTAYO A, Wong CX, Hsiao AJ, Hopewell S, et al
    Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
    BMJ. 2016;354:i4482.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: